GlassScriptPhysician profile
Amin Herati
NPI 1205153947
$159,728.93
in general payments reported to CMS, 2019-2025
26 companies · $31K in 2025
The $31K reported for 2025 was more than what 97% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,343 · 2020: $353 · 2021: $11K · 2022: $25K · 2023: $46K · 2024: $41K · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $85K · Consulting Fee: $15K · Travel and Lodging: $9,327 · Food and Beverage: $8,890.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $85,378.75 |
| Consulting Fee | $15,482.50 |
| Travel and Lodging | $9,327.23 |
| Food and Beverage | $8,889.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $133,781.83 | 2021-2025 | Urolift, Barrigel |
| Olympus America INC. | $7,319.20 | 2022-2025 | Itind System, Soltive |
| Lina Medical USA INC | $5,200.00 | 2025 | |
| Procept Biorobotics Corporation | $3,178.49 | 2021-2025 | Aquabeam Robotic System, Aquabeam System |
| Neotract INC. | $3,174.44 | 2019-2020 | |
| Boston Scientific Corporation | $2,539.31 | 2019-2025 | Ams 700, Ams 800 Artificial Urinary Sphincter, Spaceoar Vue System - 10ml |
| Olympus Corporation of The Americas | $1,621.50 | 2022-2023 | Soltive |
| Profound Medical Corp. | $541.56 | 2025 | Tulsa-Pro |
| Endo USA, INC. | $341.19 | 2024-2025 | Xiaflex, Aveed |
| Endo Pharmaceuticals INC. | $282.65 | 2019-2024 | Xiaflex |
| Valencia Technologies Corporation | $277.98 | 2025 | Ecoin Device Kit |
| Merck Sharp & Dohme LLC | $238.49 | 2022-2025 | Keytruda, Welireg, Lynparza |
| Bioprotect Medical, INC. | $234.85 | 2024-2025 | Bioprotect Balloon Implant System |
| Tolmar, INC. | $225.91 | 2023-2025 | Eligard, Jatenzo |
| Coloplast Corp | $197.40 | 2021-2024 | Speedicath |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $154.81 | 2024-2025 | |
| Laborie Medical Technologies Corp. | $127.85 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter |
| 180 Medical, INC. | $87.08 | 2020-2021 | |
| Urogen Pharma, INC. | $49.20 | 2025 | |
| Abc Home Medical Supply, INC. | $29.42 | 2022 | |
| Blue Earth Diagnostics | $28.69 | 2025 | Posluma |
| Tolmar Pharmaceuticals, INC. | $26.92 | 2022 | |
| Medtronic, INC. | $23.93 | 2023 | Interstim |
| Palette Life Sciences, INC. | $15.78 | 2022 | |
| Hollister Incorporated | $15.69 | 2023 | Vapro |
| Astrazeneca Pharmaceuticals LP | $14.76 | 2023 | Lynparza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amin Herati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.